event about "reducción del riesgo"

2 June 2025, 06:41

An experimental pill from AstraZeneca has shown a 56% reduction in the risk of breast cancer progression, according to a study presented at ASCO

Sources

Health

Personalized news feed, AI-powered search, and notifications in a more interactive experience.

app preview

google play badge